Business Segments · Capital Expenditures During Period
Orthopaedics — Capital Expenditures During Period
Stryker Orthopaedics — Capital Expenditures During Period decreased by 67.7% to $41M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 16.3%, from $49M to $41M. Over 3 years (FY 2022 to FY 2025), Orthopaedics — Capital Expenditures During Period shows an upward trend with a 19.6% CAGR.
Analysis
StatementSegment
CategoryCapital Allocation
SignalContext dependent
VolatilityVolatile
First reportedQ1 2022
Last reportedQ1 2026May 11, 2026
How to read this metric
An increase indicates investment in future capacity or efficiency, while a decrease may signal a focus on cash preservation or a mature asset base.
Detailed definition
This measures the cash spent by the Orthopaedics segment to acquire, maintain, or upgrade physical assets such as manufa...
Peer comparison
Standard capital expenditure reporting for business segments in manufacturing-heavy industries.
Metric ID:
syk_segment_orthopaedics_capital_expenditures_during_periodHistorical Data
17 periods
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $43.25M | $43.25M | $43.25M | $43.25M | $44.75M | $44.75M | $44.75M | $44.75M | $65M | $46M | $60M | $59M | $49M | $52M | $68M | $127M | $41M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +3.5% | +0.0% | +0.0% | +0.0% | +45.3% | -29.2% | +30.4% | -1.7% | -16.9% | +6.1% | +30.8% | +86.8% | -67.7% |
| YoY Change | — | — | — | — | +3.5% | +3.5% | +3.5% | +3.5% | +45.3% | +2.8% | +34.1% | +31.8% | -24.6% | +13.0% | +13.3% | +115.3% | -16.3% |
Range$41M – $127M
CAGR-1.3%
Avg YoY Growth+17.6%
Median YoY Growth+3.5%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Stryker's orthopaedics — capital expenditures during period?
- Stryker (SYK) reported orthopaedics — capital expenditures during period of $41M in Q1 2026.
- How has Stryker's orthopaedics — capital expenditures during period changed year-over-year?
- Stryker's orthopaedics — capital expenditures during period decreased by 16.3% year-over-year, from $49M to $41M.
- What is the long-term trend for Stryker's orthopaedics — capital expenditures during period?
- Over 3 years (2022 to 2025), Stryker's orthopaedics — capital expenditures during period has grown at a 19.6% compound annual growth rate (CAGR), from $173M to $296M.
- What does orthopaedics — capital expenditures during period mean?
- The amount of money invested in physical assets for the orthopedic business.